BE364933A - - Google Patents

Info

Publication number

BE364933A

BE364933A BE364933DA BE364933A BE 364933 A BE364933 A BE 364933A BE 364933D A BE364933D A BE 364933DA BE 364933 A BE364933 A BE 364933A

Authority

BE

Belgium

Prior art keywords

mark

various

lines

place

electro

Prior art date

Links

• Espacenet
• Global Dossier
• Discuss

• 230000000903 blocking effect Effects 0.000 claims description 34
• 210000000056 organ Anatomy 0.000 claims description 24
• 230000011664 signaling Effects 0.000 claims description 9
• 238000009434 installation Methods 0.000 claims description 6
• 150000001768 cations Chemical class 0.000 claims description 2
• 102100026933 Myelin-associated neurite-outgrowth inhibitor Human genes 0.000 claims 1
• ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims 1
• 230000000994 depressogenic effect Effects 0.000 claims 1
• 230000000875 corresponding effect Effects 0.000 description 42
• 230000000694 effects Effects 0.000 description 9
• 238000012544 monitoring process Methods 0.000 description 7
• 238000010586 diagram Methods 0.000 description 5
• 238000011160 research Methods 0.000 description 3
• 241000283074 Equus asinus Species 0.000 description 2
• 239000003990 capacitor Substances 0.000 description 2
• 239000003086 colorant Substances 0.000 description 2
• 150000002500 ions Chemical class 0.000 description 2
• NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
• 230000003287 optical effect Effects 0.000 description 2
• 238000004804 winding Methods 0.000 description 2
• 208000032544 Cicatrix Diseases 0.000 description 1
• 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 1
• 206010026749 Mania Diseases 0.000 description 1
• 206010039580 Scar Diseases 0.000 description 1
• 238000012550 audit Methods 0.000 description 1
• 238000004891 communication Methods 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• RWYFURDDADFSHT-RBBHPAOJSA-N diane Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1.C1=C(Cl)C2=CC(=O)[C@@H]3CC3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RWYFURDDADFSHT-RBBHPAOJSA-N 0.000 description 1
• 238000006073 displacement reaction Methods 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 230000003100 immobilizing effect Effects 0.000 description 1
• 238000003780 insertion Methods 0.000 description 1
• 230000037431 insertion Effects 0.000 description 1
• 238000007726 management method Methods 0.000 description 1
• 239000003550 marker Substances 0.000 description 1
• 238000000034 method Methods 0.000 description 1
• 238000012806 monitoring device Methods 0.000 description 1
• 239000003415 peat Substances 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 208000014745 severe cutaneous adverse reaction Diseases 0.000 description 1